Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease.
Standard
Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease. / Rudolph, Volker; Steven, Daniel; Gehling, Ursula; Goldmann, Britta; Rudolph, Tanja Katharina; Friedrichs, Kai; Meinertz, Thomas; Heitzer, Thomas; Baldus, Stephan.
in: FREE RADICAL BIO MED, Jahrgang 42, Nr. 4, 4, 2007, S. 460-465.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease.
AU - Rudolph, Volker
AU - Steven, Daniel
AU - Gehling, Ursula
AU - Goldmann, Britta
AU - Rudolph, Tanja Katharina
AU - Friedrichs, Kai
AU - Meinertz, Thomas
AU - Heitzer, Thomas
AU - Baldus, Stephan
PY - 2007
Y1 - 2007
N2 - Activation of leukocytes, in particular polymorphonuclear neutrophils (PMN), is considered an early event in unstable coronary disease. Upon activation PMN liberate myeloperoxidase (MPO), an enzyme which binds to the vessel wall and depletes vascular NO bioavailability. Using coronary balloon angioplasty as a trigger to provoke coronary plaque injury, we assessed the time course of neutrophil activation, local and peripheral levels of myeloperoxidase, and systemic vascular NO bioavailability in patients with stable coronary artery disease. Twenty-four patients with stable CAD were enrolled prior to undergoing percutaneous interventions (PCI, n=14) and diagnostic coronary angiography (n=10), respectively. Following angioplasty arterial MPO plasma levels increased (231.5+/-67.6 to 273.8+/-80.4 pg/mg protein; P
AB - Activation of leukocytes, in particular polymorphonuclear neutrophils (PMN), is considered an early event in unstable coronary disease. Upon activation PMN liberate myeloperoxidase (MPO), an enzyme which binds to the vessel wall and depletes vascular NO bioavailability. Using coronary balloon angioplasty as a trigger to provoke coronary plaque injury, we assessed the time course of neutrophil activation, local and peripheral levels of myeloperoxidase, and systemic vascular NO bioavailability in patients with stable coronary artery disease. Twenty-four patients with stable CAD were enrolled prior to undergoing percutaneous interventions (PCI, n=14) and diagnostic coronary angiography (n=10), respectively. Following angioplasty arterial MPO plasma levels increased (231.5+/-67.6 to 273.8+/-80.4 pg/mg protein; P
M3 - SCORING: Zeitschriftenaufsatz
VL - 42
SP - 460
EP - 465
JO - FREE RADICAL BIO MED
JF - FREE RADICAL BIO MED
SN - 0891-5849
IS - 4
M1 - 4
ER -